Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev Med Interne ; 37(1): 5-12, 2016 Jan.
Artigo em Francês | MEDLINE | ID: mdl-26410419

RESUMO

INTRODUCTION: Symptomatic extramedullary hematopoiesis (EH) is a rare but potentially severe phenomenon which occurs in ß-thalassemia. There are no treatment guidelines. METHODS: Retrospective single centre study including the cases of symptomatic EH encountered between 1997 and 2014 in a unit specialised in red blood cell genetic disorders. Description of clinical, biological and radiological characteristics of the patients, treatments received, and outcomes. RESULTS: Among 182 ß-thalassemia patients followed during the study period, 7 cases of symptomatic EH were diagnosed. They were 5 men and 2 women, and their mean age was 37 years. Four patients were splenectomised, two patients were regularly transfused, and four patients had already received erythropoietin. EH was localised in intravertebral areas and responsible for dorsal spinal cord compression in 5 patients, in paravertebral dorsal area in 1 patient, and in presacral area in 1 patient. The mean hemoglobin level at diagnosis was 7.9 g/dL. Treatment administered included: red cell transfusion in 6 cases, associated with hydroxyurea in 5 cases and/or radiotherapy in 3 patients. One patient was treated with surgery and HU. After a median follow-up of 41 months, clinical recovery was complete in 2 patients and partial in 5 patients. CONCLUSION: EH must be suspected in ß-thalassemia in patients presenting clinical signs of organ compression, and a typical radiological aspect. The functional prognosis depends on the rapidity of treatment, which includes red blood cell transfusion, hydroxyurea, radiotherapy, and rarely surgery. Long-term outcome is uncertain.


Assuntos
Hematopoese Extramedular/fisiologia , Talassemia beta/fisiopatologia , Adulto , Feminino , Hematopoese Extramedular/genética , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto Jovem , Talassemia beta/genética
2.
Rev Med Interne ; 36(11): 753-9, 2015 Nov.
Artigo em Francês | MEDLINE | ID: mdl-26119345

RESUMO

Hyper-reactive malarial splenomegaly is a rare and severe form of chronic malaria. This condition is a common cause of splenomegaly in endemic areas. The pathophysiology of hyper-reactive malarial splenomegaly involves an intense immune reaction (predominantly B cell-driven) to repeated/chronic infections with Plasmodium sp. The diagnosis may be difficult, due to a poorly specific clinical presentation (splenomegaly, fatigue, cytopenias), a long delay between residence in a malaria-endemic area and onset of symptoms, and a frequent absence of parasites on conventional thin and thick blood smears. A strongly contributive laboratory parameter is the presence of high levels of total immunoglobulin M. When the diagnostic of hyper-reactive malarial splenomegaly is considered, search for anti-Plasmodium antibodies and Plasmodium nucleic acids (genus and species) by PCR is useful. Diagnosis of hyper-reactive malarial splenomegaly relies on the simultaneous presence of epidemiological, clinical, biological and follow-up findings. Regression of both splenomegaly and hypersplenism following antimalarial therapy allows the differential diagnosis with splenic lymphoma, a common complication of hyper-reactive malarial splenomegaly. Although rare in Western countries, hyper-reactive malarial splenomegaly deserves increased medical awareness to reduce the incidence of incorrect diagnosis, to prevent progression to splenic lymphoma and to avoid splenectomy.


Assuntos
Malária Falciparum/diagnóstico , Malária Falciparum/tratamento farmacológico , Esplenomegalia/imunologia , Anticorpos/sangue , Antimaláricos/uso terapêutico , Diagnóstico Diferencial , Humanos , Imunoglobulina M/sangue , Malária Falciparum/epidemiologia , Plasmodium falciparum/genética , Plasmodium falciparum/imunologia , Esplenomegalia/tratamento farmacológico , Esplenomegalia/epidemiologia
3.
Ann Urol (Paris) ; 29(6-7): 382-8, 1995.
Artigo em Francês | MEDLINE | ID: mdl-8687177

RESUMO

The authors report a retrospective series of 174 patients with urolithiasis. They were all age between 65 and 88 years. This group represents one tenth of all patients treated for urinary stones in the Urology department of Sfax over the last decade. Neither the clinical symptoms nor radiological findings observed in this group differed from those other patients hospitalized for urolithiasis; on the other hand associated diseases related to aging appear to be well represented which alters the management, prognosis and outcome in this type of patients.


Assuntos
Envelhecimento , Cálculos Urinários/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Comorbidade , Diabetes Mellitus/epidemiologia , Feminino , Seguimentos , Humanos , Hipertensão/epidemiologia , Masculino , Obesidade/epidemiologia , Prognóstico , Hiperplasia Prostática/epidemiologia , Radiografia , Insuficiência Renal/epidemiologia , Estudos Retrospectivos , Fatores Sexuais , Resultado do Tratamento , Tunísia/epidemiologia , Cálculos Urinários/diagnóstico por imagem , Cálculos Urinários/metabolismo , Cálculos Urinários/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...